Latest News and Press Releases

Endurkaup í viku 6

Prof. Carl D. Regillo, MD, presented clinical data from the Phase 1b trial evaluating Breye Therapeutics’ lead candidate, danegaptide, in 24 patients with non-proliferative diabetic retinopathy (NPDR)...

Aktietilbagekøbsprogram i Alm. Brand A/S Transaktioner 2. februar 2026 – 6. februar 2026Alm. Brand A/S offentliggjorde i selskabsmeddelelse nr. 21/2025 et aktietilbagekøbsprogram på op til 835,2...

Alm. Brand A/S share buy-back program Transactions during 2 February 2026 – 6 February 2026On 5 March 2025, Alm. Brand A/S announced a share buy-back program of up to DKK 835.2 million, as described...

Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global ethylene carbonate market was valued at US$ 391.51 million in 2025 and is projected to reach US$ 741.85 million by 2035, at a CAGR of 6.6%...

Roubaix – 9 février 2026 – Dans un contexte où les entreprises doivent jongler avec des volumes de données sans précédent, exécuter des tâches toujours plus hétérogènes et maîtriser leurs coûts comme...

Roubaix – February 9th 2026 – In a context where organizations have to juggle with unprecedented volumes of data, run even more heterogeneous tasks all while keeping control of their costs and...

KØBENHAVN, Danmark, 9. februar 2026 – Bavarian Nordic A/S (OMX: BAVA) meddeler, at aktietilbagekøbsprogrammet, der blev offentliggjort og iværksat den 7. januar 2026, nu er afsluttet, da aktier til en...

COPENHAGEN, Denmark, February 9, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on January 7, 2026, has now been completed,...

9 February 2026: Borregaard ASA (“Borregaard”, OSE ticker: BRG) Borregaard employees have been given the opportunity to buy shares at a discounted price. The offer is valid from 9 February up to and...